| Title : Vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed beta-cell function in patients with type 2 diabetes - Mari_2005_J.Clin.Endocrinol.Metab_90_4888 |
| Author(s) : Mari A , Sallas WM , He YL , Watson C , Ligueros-Saylan M , Dunning BE , Deacon CF , Holst JJ , Foley JE |
| Ref : J Clinical Endocrinology Metab , 90 :4888 , 2005 |
| Abstract : Mari_2005_J.Clin.Endocrinol.Metab_90_4888 |
| ESTHER : Mari_2005_J.Clin.Endocrinol.Metab_90_4888 |
| PubMedSearch : Mari_2005_J.Clin.Endocrinol.Metab_90_4888 |
| PubMedID: 15886245 |
Mari A, Sallas WM, He YL, Watson C, Ligueros-Saylan M, Dunning BE, Deacon CF, Holst JJ, Foley JE (2005)
Vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed beta-cell function in patients with type 2 diabetes
J Clinical Endocrinology Metab
90 :4888
Mari A, Sallas WM, He YL, Watson C, Ligueros-Saylan M, Dunning BE, Deacon CF, Holst JJ, Foley JE (2005)
J Clinical Endocrinology Metab
90 :4888